Adding Anxiety as Qualifier for Medical Cannabis Increases Number of Certifications

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 11, 2025.

via HealthDay

FRIDAY, July 11, 2025 -- Adding anxiety disorders as a qualifying condition for medical cannabis in Pennsylvania was associated with an increase in certifications, according to a research letter published online July 7 in the Annals of Internal Medicine.

Coleman Drake, Ph.D., from the University of Pittsburgh School of Public Health, and colleagues examined whether Pennsylvania adding anxiety disorders as a qualifying condition to obtain medical cannabis in July 2019 was associated with changes in the distribution of qualifying conditions and the total number of certifications.

A total of 1,730,600 certifications were issued between November 2017 and December 2023, and of these, 1,593,790 were issued after anxiety disorders were added as a qualifying condition. The researchers found that throughout this period, there was a rapid increase in the number of certifications issued per month, from about 11,000 certifications in June 2019 to 30,000 in December 2023, which were mostly related to increases in certifications for anxiety. Before anxiety was added, 67.07 and 15.84 percent of certifications had chronic pain and posttraumatic stress disorder (PTSD) as qualifying conditions, respectively. After the addition of anxiety, 60.26 percent of certifications were for anxiety, while 41.47 and 10.97 percent of certifications were for chronic pain and PTSD, respectively.

"Adding anxiety to the program may inadvertently signal to patients that cannabis is effective for treating it, despite the lack of evidence, which is concerning," Drake said in a statement. "At the same time, cannabis may improve some health outcomes, relative to alternative treatments, depending on the individual and their circumstances."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-12 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords